InsiderTrades

Form 4/A for CELU Celularity Inc

Accepted 2025-06-04 00:00:00 ET · period of report 2025-04-13 · accession 0001641172-25-013629 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2025-06-04 2025-04-13 CELU Hariri Robert J CEO, Dir F - Tax $1.64 -1,154 2.85M -0.0% -$1,893
DA 2025-06-04 2025-04-13 CELU Hariri Robert J CEO, Dir M - OptEx $0.00 +3,281 2.85M +0.1% $0
DA 2025-06-04 2025-04-13 CELU Hariri Robert J CEO, Dir M - OptEx $0.00 -3,281 3,281 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-04-13 F D 1,154 $1.64 2,851,454 D — —
2 Common Class A Common Stock 2025-04-13 M A 3,281 $0.00 2,852,608 D — — (F1) Represents the conversion upon vesting of restricted stock units (RSUs) into Class A Common Stock. On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 28, 2022.
3 Derivative Restricted Stock Units 2025-04-13 M D 3,281 $0.00 3,281 D — · — to — 3,281 Class A Common Stock (F3) Each restricted stock unit is the economic equivalent of one share of Celularity Inc. Class A Common Stock. (F4) On April 13, 2022, the reporting person was granted 13,123 RSUs, 25% of which vested on April 13, 2025. The Class A Common Stock into which such vested RSUs converted on April 13, 2025 is reported in Table I on this Form 4.